ID

17835

Description

NCT00334568/ GSK-AVA100193: M.Alzheimer GSK A 24 week double-blind, randomized, placebo-controlled, parallel-group dose-raging study to investigate the effects of rosiglitazone (extended release tablets) on cognition in subjects with mild to moderate Alzheimer´s disease. Medicine: rosiglitazone, Condition: Alzheimer´s Disease, Phase: 2, Clinical Study ID: AVA 100193, Sponsor: GSK. This ODM contains the Pharmacogenetic and Pharmacogenomic Research.

Keywords

Versions (2)
  1. 10/4/16 10/4/16 -
  2. 12/5/16 12/5/16 -
Uploaded on

October 4, 2016

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

NCT00334568/ GSK-AVA100193: M.Alzheimer GSK - Pharmacogenetic and Pharmacogenomic Research

English

NCT00334568/ GSK-AVA100193: M.Alzheimer GSK - Pharmacogenetic and Pharmacogenomic Research

1 forms  
General Information
Description

General Information

Protocol Identifier: AVA100193
Description

Protocol Identifier

Data type

boolean

Subject Identifier
Description

Subject Identifier

Data type

integer

PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic Research
Description

PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic Research

Has informed consent been obtained for PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic Research?
Description

Informed Consent

Data type

boolean

If yes, record the date informed consent obtained for PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic research
Description

Date

Data type

date

If no, select one reason
Description

Reason for not obtaining informed consent

Data type

text

If Other, please specify
Description

Specification of Other

Data type

text

Blood sample collection (DNA)
Description

Blood sample collection (DNA)

Has a blood sample been collected for PGx-pharmacogenetic research?
Description

Has a blood sample been collected for PGx-pharmacogenetic research?

Data type

boolean

If yes, record the date samples taken.
Description

Date

Data type

date

Withdrawal of consent
Description

Withdrawal of consent

Has subject withdrawn consent for PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic research?
Description

Has subject withdrawn consent for PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic research?

Data type

boolean

Blood sample Destruction
Description

Blood sample Destruction

Has a request been made for sample destruction?
Description

Has a request been made for sample destruction?

Data type

boolean

If yes, specify reason
Description

If yes, specify reason

Data type

text

If other, please specify
Description

Other

Data type

text

Alias
UMLS CUI [1]
C0205394
Back to the top of the page

Similar models

NCT00334568/ GSK-AVA100193: M.Alzheimer GSK - Pharmacogenetic and Pharmacogenomic Research

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
General Information
Protocol Identifier
Item
Protocol Identifier: AVA100193
boolean
Subject Identifier
Item
Subject Identifier
integer
Item Group
PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic Research
Informed Consent
Item
Has informed consent been obtained for PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic Research?
boolean
Date
Item
If yes, record the date informed consent obtained for PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic research
date
Item
If no, select one reason
text
Reason for not obtaining informed consent
Code List
If no, select one reason
CL Item
Subject declined (1)
CL Item
Subject not asked by Investigator  (2)
CL Item
Other (specify) (3)
Specification of Other
Item
If Other, please specify
text
Item Group
Blood sample collection (DNA)
Has a blood sample been collected for PGx-pharmacogenetic research?
Item
Has a blood sample been collected for PGx-pharmacogenetic research?
boolean
Date
Item
If yes, record the date samples taken.
date
Item Group
Withdrawal of consent
Has subject withdrawn consent for PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic research?
Item
Has subject withdrawn consent for PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic research?
boolean
Item Group
Blood sample Destruction
Has a request been made for sample destruction?
Item
Has a request been made for sample destruction?
boolean
Item
If yes, specify reason
text
If yes, specify reason
Code List
If yes, specify reason
CL Item
Subject requested (1)
CL Item
Other (specify) (2)
Other
Item
If other, please specify
text
C0205394 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial